Heath Stotts
Optometrist · Enid, OKNPI 1992051148
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Johnson & Johnson Vision Care, Inc. accounts for 66.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $103 and has fallen 59.2% since, to $42 in 2025. That places this record below the midpoint for optometrist clinicians in OK, where the typical reported total is $560.
Across 25 payments — averaging $19.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$321
- Optos, Inc.$40
- Coopervision Inc.$40
- Bausch & Lomb Americas Inc.$31
- Astellas Pharma US Inc$27
- Eyevance Pharmaceuticals LLC$22
What the payments were for
- Food & beverage$480100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 16 | $321 |
| Optos, Inc. | 2 | $40 |
| Coopervision Inc. | 3 | $40 |
| Bausch & Lomb Americas Inc. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $27 |
| Eyevance Pharmaceuticals LLC | 1 | $22 |
How this compares
$480 in reported general payments places this provider in the 45th percentile of 714 optometrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 13 | $8,242 |
| LumiganBimatoprost | 23 | $6,540 |
| CombiganBrimonidine Tartrate/Timolol | 16 | $3,907 |
| Brimonidine Tartrate | 46 | $2,354 |
| Loteprednol Etabonate | 13 | $1,550 |
| Prednisolone Acetate | 50 | $1,399 |
| Latanoprost | 138 | $1,325 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 31 | $1,256 |
| Ketorolac Tromethamine | 18 | $482 |
| ErythromycinErythromycin Base | 37 | $399 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 29 | $290 |
| Timolol Maleate | 32 | $275 |
| MoxifloxacinMoxifloxacin Hcl | 11 | $236 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Enid
- Selina McGeeEdmond$1.1M
- Nathan LighthizerTahlequah$1M
- Lindsey BullTulsa$218K
- Jeff MillerTahlequah$67K
- Joseph PhillipsOklahoma City$52K
- Wesley DerosierTulsa$48K
- Charles WhittleTahlequah$28K
- Latricia PackTahlequah$25K
- Scott ForesterOklahoma City$17K
- Cindy ShanTahlequah$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.